Filing Details
- Accession Number:
- 0001062993-24-014476
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-06 09:07:40
- Reporting Period:
- 2024-08-02
- Accepted Time:
- 2024-08-06 09:07:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1607962 | Rewalk Robotics Ltd. | LFWD | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1877823 | Jeannine Lynch | C/O Rewalk Robotics Ltd. 3 Hatnufa St., P.o. Box 161 Yokneam Illit L3 20692203 | Vp Of Market Access & Strategy | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares, Par Value Nis 1.75 Per Share | Disposition | 2024-08-02 | 1,783 | $3.84 | 49,283 | No | 4 | S | Indirect | ESOP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | ESOP |
Footnotes
- Represents Ordinary Shares sold in the open market on August 2, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 2, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan (the "Plan") on August 2, 2022 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.
- Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $3.73 to $4.29. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.